Profile: Antares Pharma, Inc. is involved in developing and commercializing novel therapeutic products utilizing advanced drug delivery systems. Our products are patient focused; they typically improve safety and efficacy, reduce side effects & enable us to deliver a lower dose. Our advanced drug delivery systems are also well positioned for life cycle extension options. Our estradiol gel is prescribed for the treatment of moderate to severe hot flashes (vasomotor symptoms) associated with menopause. Our Female Testosterone ATD™ gel is a gel formulation of bioidentical testosterone used in the treatment of FSD (female sexual dysfunction).
The company was founded in 2001, has revenues of USD 1-5 Million, has ~20 employees and is ISO 9001, CE certified. AMEX:AIS (SEC Filings)
FDA Registration Number: 2182861
6 Products/Services (Click for related suppliers)
|
• Disposable Mini-Needle Injectors |
• Estradiol Gel |
• Female Testosterone Gel |
• Fixed-Dose Pen Injectors |
• Non-Electric Powered Fluid Injector (FDA Code: KZE / 880.5430) A nonelectrically powered fluid injector is a nonelectrically powered device used by a health care provider to give a hypodermic injection by means of a narrow, high velocity jet of fluid which can penetrate the surface of the skin and deliver the fluid to the body. It may be used for mass inoculations. |
• Non-invasive Drug Delivery System |